36 citations
,
November 2016 in “European journal of dermatology/EJD. European journal of dermatology”
This review examines systemic drugs that can cause changes in haircolor and emphasizes the importance of reporting these adverse events, but it does not include new clinical outcomes.
This case study reports a man with rapid hair thinning, whitening, and sparse beard, linked to an increased proportion of hair follicles in catagen or telogen phase and peribulbar lymphocytic infiltrate.
June 2021 in “Clinical neuropsychopharmacology and therapeutics”
This paper reviews the haircolorchanges associated with valproic acid treatment, noting only a few reported instances of bleaching or darkening, and reports no new findings.
The user is experiencing severe hair loss and colorchange despite low testosterone levels and healthy lifestyle changes. They have tried ketoconazole shampoo and consulted a dermatologist, who found no scalp issues but suggested using Toppik for coverage.
A 20-year-old male experienced bald spots and used minoxidil, which led to hair regrowth but also premature graying. He seeks advice on reversing graying through diet or supplements like catalase, while another user suggests vitamin D3 and sesame for haircolor.
The user is using oral minoxidil for hair growth and is considering adding topical latanoprost, but is concerned about potential eye colorchange. They are seeking advice on the effectiveness of latanoprost for hair thickening and the risk of eye colorchange.
A user noticed a colorchange in their hair loss solution containing minoxidil, finasteride, retinoic acid, and hydrocortisone after storing it for several months. They are concerned about the effectiveness of the solution due to potential oxidation.
The conversation is about using Bimatoprost for hair growth, with concerns about potential side effects like eye colorchange and fat atrophy. Users discuss combining it with other treatments like Minoxidil and Finasteride, and sourcing Bimatoprost in bulk.
Is scalp micropigmentation safe?Providers describe scalp micropigmentation as low-risk when a trained practitioner uses sterile single-use equipment, but that is a provider claim rather than a regulatory finding: pigment allergy, infection and colour change are documented risks of cosmetic tattooing.